|
gptkbp:instanceOf
|
gptkb:chemical_compound
|
|
gptkbp:affects
|
central nervous system
|
|
gptkbp:antidote
|
no specific antidote
|
|
gptkbp:boilingPoint
|
187 °C (decomposes)
|
|
gptkbp:CASNumber
|
50-36-2
|
|
gptkbp:chemicalFormula
|
C17H21NO4
|
|
gptkbp:discoveredBy
|
gptkb:Albert_Niemann
|
|
gptkbp:discoveredIn
|
1859
|
|
gptkbp:excretion
|
urine
|
|
gptkbp:foundIn
|
gptkb:Erythroxylum_coca
|
|
gptkbp:halfLife
|
0.7–1.5 hours
|
|
gptkbp:hasAddictivePotential
|
yes
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
benzoylmethylecgonine
|
|
gptkbp:inhibitedBy
|
serotonin reuptake
dopamine reuptake
norepinephrine reuptake
|
|
gptkbp:isSchedule
|
gptkb:Class_A_(UK)
gptkb:Schedule_II_(US)
List I (UN)
|
|
gptkbp:IUPACName
|
methyl (1R,2R,3S,5S)-3-benzoyloxy-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate
|
|
gptkbp:legalStatus
|
illegal in most countries
|
|
gptkbp:medicalUse
|
local anesthetic (rarely)
|
|
gptkbp:meltingPoint
|
98 °C
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:molecularWeight
|
303.353 g/mol
|
|
gptkbp:otherName
|
cocaine
|
|
gptkbp:predecessor
|
crack cocaine
freebase cocaine
|
|
gptkbp:psychoactive
|
yes
|
|
gptkbp:PubChem_CID
|
gptkb:CHEMBL108
gptkb:CHEBI:27958
446220
|
|
gptkbp:routeOfAdministration
|
oral
inhalation
intravenous
intranasal
|
|
gptkbp:sideEffect
|
gptkb:arrhythmia
addiction
myocardial infarction
stroke
anxiety
hypertension
paranoia
seizures
insomnia
mydriasis
tachycardia
euphoria
hyperthermia
|
|
gptkbp:UNII
|
U3C868YI2Y
|
|
gptkbp:usedAs
|
stimulant
|
|
gptkbp:bfsParent
|
gptkb:Freebase_cocaine
|
|
gptkbp:bfsLayer
|
6
|